Advancing China’s Disease Control and Prevention System: A Strategic Roadmap for High-Quality Development  

作　　者：Zhi Zeng Hao Chen Qingfeng Chen Yuan Wang Lieyu Huang Chengyu Lai Kaixuan Liu Haotian Pan Ying Cui 

机构地区：[1]Office of Policy and Planning Research,Chinese Center for Disease Control and Prevention&Chinese Academy of Preventive Medicine,Beijing,China

出　　处：《China CDC weekly》2024年第38期975-978,共4页中国疾病预防控制中心周报（英文）

摘　　要：China’s Disease Control and Prevention(DCP)system has played a critical role in protecting population health and ensuring socioeconomic stability(1).Over the past two decades,China has made significant advancements in disease surveillance,response,and control,particularly following the 2003 severe acute respiratory syndrome(SARS)outbreak and the 2009 national healthcare reforms(2–3).These initiatives have substantially strengthened the national DCP system and led to improved public health outcomes,including the effective control of outbreaks such as avian influenza and coronavirus disease 2019(COVID-19).Consequently,the incidence of major epidemics has declined markedly(1).

关 键 词：STRENGTHENED QUALITY STRATEGIC 

分 类 号：R183[医药卫生—流行病学]